Pharmafile Logo
Pharmafocus logo
Advanced Search
1920px-hiv-budding-color

Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV

December 10, 2018
Sales and Marketing HIV, Trump, US government, feotal tissue, mice, research

The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, …

News

Gilead names Roche veteran Daniel O’Day as new CEO

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Gilead, Roche, appointment

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role …

News
bad_homburg_fresenius_zentrale

Akorn CEO resigns after $4.3bn Fresenius deal falls through

December 10, 2018
Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics

The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit

Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …

News
28246711066_52e38bc591_z

Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit

December 7, 2018
Medical Communications Matt Hancock, NHS, UK, brexit, no-deal

British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …

News
gilead-sciences

NICE give go-ahead to Gilead’s Yescarta for adults with lymphoma

December 7, 2018
Medical Communications Cancer, Cost, Gilead, NHS, NICE, Yescarta, access

The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma. Gilead’s treatment will …

News
gehrynovartis

Novartis CEO calls for cultural shift to cater for millennial generation

December 7, 2018
Medical Communications Business, company, culture, millenials. Novartis

The CEO of Swiss multinational Novartis has said that he wants to ‘un-boss’ the multi-billion pound company while relaxing the …

News
AstraZeneca

AstraZeneca’s head and neck cancer treatment Imfinzi falls flat in Phase III trials

December 7, 2018
Medical Communications AstraZeneca, Cancer, oncology, phase III, treatment

AstraZeneca’s immunotherapy treatment Imfinzi has failed to meet its primary goal in treating head and neck cancer in the Phase …

News
jeffrey_hackman

EUSA Pharma take on Novelion CEO Jeffrey Hackman to lead US expansion

December 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Hertfordshire-based speciality pharma firm EUSA Pharma has appointed Jeffrey S Hackman as President of the company’s United States operations. …

Appointment

UCB to invest £1 billion into UK R&D

December 6, 2018
Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research

The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …

News

British researchers sequences 100,000 whole genomes

December 6, 2018
Research and Development Matt Hancock, digital, genome, personalised medicnie

British researchers have sequenced 100,000 whole genomes as part of an effort to improve understanding of rare diseases and move …

News

Bayer to cut 12,000 jobs by 2025

December 6, 2018
Business Services, Manufacturing and Production, Sales and Marketing Bayer, Germany, Jobs, manfucaturing, monsanto, production

German pharma giant Bayer is set to cut 12,000 jobs by 2025 as part of a plan to focus on …

News

Takeda shareholders approve $62bn Shire acquisition

December 6, 2018
Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition

Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …

News

Sanofi announce cull of 670 French jobs

December 6, 2018
Business Services, Manufacturing and Production CGT, France, Jobs, Macron, Sanofi, gilet jaunes, yellow jackets

French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The …

News

Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline

December 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …

Feature
amgen_flag

Amgen unveils double whammy of data for its investigational cancer immunotherapies at ASH 2018

December 5, 2018
Research and Development ASH 2018, Amgen, Cancer, acute myeloid leukaemia, myeloma, pharma

Amgen has presented the first clinical data at the American Society of Hematology (ASH) Annual Meeting 2018 for two investigational …

News
acute_leukemia-all

New diagnostic test can detect any cancer type in minutes with 90% accuracy

December 5, 2018
Research and Development Australia, Cancer, pharma

Researchers at the University of Queensland have a test which can rapidly detect the presence of cancer in a patient’s …

News
shutterstock_212432119

UK Government announces first-of-its-kind Vaccines Manufacturing Innovation Centre

December 5, 2018
Research and Development UK, pharma, vaccines

Plans for a Vaccines Manufacturing Innovation Centre in the UK have been unveiled by Business Secretary Greg Clark, in a …

News
rocherooflr

Roche’s first-line Tecentriq combo scores accelerated FDA review

December 5, 2018
Research and Development ASH 2018, Cancer, Roche, lung cancer, pharma, tecentriq

Roche’s immunotherapy Tecentriq has secured Priority Review from the FDA, the company has announced, in combination with carboplatin and etoposide …

News
janssen_latest_logo_on_sign_closer

Darzalex “significantly reduces” disease progression and death in multiple myeloma at ASH 2018

December 5, 2018
Research and Development ASH 2018, Janssen, darzalex, multiple myeloma, pharma

Janssen has taken the opportunity at the American Society of Hematology (ASH) Annual Meeting 2018 to unveil new Phase 3 …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026